Muhammad Asim Khan (Case Western Re Professor Emeritus of Medicine
Ankylosing Spondylitis and Axial Spondyloarthritis
Muhammad Asim Khan (Case Western Re Professor Emeritus of Medicine
Ankylosing Spondylitis and Axial Spondyloarthritis
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Ankylosing spondylitis (AS), currently grouped under the term axial spondyloarthritis (axSpA), is a chronic form of arthritis that causes inflammation of the spine and other joints. This book provides clear and practical information on symptoms, diagnosis, treatments, and daily life with AS for patients and their families.
Andere Kunden interessierten sich auch für
- Muhammad Asim Khan (Prof Professor in the Division of RheumatologyAnkylosing Spondylitis36,99 €
- Systemic Lupus Erythematosus43,99 €
- ABC of Rheumatology45,99 €
- Til LuchauAdvanced Myofascial Techniques: Volume 268,99 €
- Donald E. Thomas (Arthritis and Pain Associates of PG County)The Lupus Encyclopedia43,99 €
- Anne C. Brower (Professor and Eastern Virginia Chair of RadiologyArthritis in Black & White179,99 €
- Andrew BrownEureka: Rheumatology and Orthopaedics38,99 €
-
-
-
Ankylosing spondylitis (AS), currently grouped under the term axial spondyloarthritis (axSpA), is a chronic form of arthritis that causes inflammation of the spine and other joints. This book provides clear and practical information on symptoms, diagnosis, treatments, and daily life with AS for patients and their families.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- The Facts Series
- Verlag: Oxford University Press
- 2 Revised edition
- Seitenzahl: 224
- Erscheinungstermin: 5. April 2023
- Englisch
- Abmessung: 194mm x 126mm x 13mm
- Gewicht: 278g
- ISBN-13: 9780198864158
- ISBN-10: 0198864159
- Artikelnr.: 64105311
- The Facts Series
- Verlag: Oxford University Press
- 2 Revised edition
- Seitenzahl: 224
- Erscheinungstermin: 5. April 2023
- Englisch
- Abmessung: 194mm x 126mm x 13mm
- Gewicht: 278g
- ISBN-13: 9780198864158
- ISBN-10: 0198864159
- Artikelnr.: 64105311
Dr Khan obtained his medical degree in 1965 followed by postgraduate training in the UK and US. In 1973 he served on the faculty of Case Western Reserve University Cleveland, Ohio, and retired as a tenured full Professor of Medicine in 2012 to become Professor Emeritus of Medicine. He is Fellow of the Royal College of Physicians (FRCP), Master of American College of Physicians (MACP) and American College of Rheumatology (MACR), and a founding member of ASAS, SPARTAN, and GRAPPA devoted to research in AS and SpA. His awards include Distinguished Rheumatologist Award from ACR, Lifetime Achievement Awards from SPARTAN and Ohio Association of Rheumatologists, Spondylitis Association of America's award for "Lifetime of dedication and devotion to people with spondylitis", and their Greg Field Award given to "individuals with AS who have persevered and gone on to be of service to others". He has authored or co-authored seven books on AS-axSpA, over 50 book chapters, and over 250 journal articles.
1: What is ankylosing spondylitis?
2: What is axial spondyloarthritis?
3: What is the underlying cause? HLA-B27 and other disease predisposing genes
4: Disease prevalence
5: Early symptoms
6: Eye inflammation (acute anterior uveitis)
7: Other manifestations
8: Findings on clinical examination and laboratory tests
9: Radiology, MRI, and CT
10: Diagnosis of other forms of SpA and 'look-alikes'
11: Other causes of chronic back pain
12: Assessment of disease activity and functional impairment
13: Patient education
14: Exercise and physical therapy
15: Management: An Overview
16: Management: Patient's role
17: Management: Rheumatologist's role
18: NSAIDs and conventional DMARDs
19: Tumor Necrosis Factor Inhibitors
20: IL-17 and IL-23 inhibitors; and targeted synthetic DMARDs
21: Living with the disease and its socioeconomic impact
22: Fused (ankylosed) spine and risk of fractures
23: Surgical treatment
24: Nontraditional (complementary or alternative) therapy
25: Disease course and effect on lifespan
26: Illustrative case histories
Appendix 1: Patient support groups and organizations
Appendix 2: Glossary
Appendix 3: List of abbreviations
Appendix 4: References and further reading
2: What is axial spondyloarthritis?
3: What is the underlying cause? HLA-B27 and other disease predisposing genes
4: Disease prevalence
5: Early symptoms
6: Eye inflammation (acute anterior uveitis)
7: Other manifestations
8: Findings on clinical examination and laboratory tests
9: Radiology, MRI, and CT
10: Diagnosis of other forms of SpA and 'look-alikes'
11: Other causes of chronic back pain
12: Assessment of disease activity and functional impairment
13: Patient education
14: Exercise and physical therapy
15: Management: An Overview
16: Management: Patient's role
17: Management: Rheumatologist's role
18: NSAIDs and conventional DMARDs
19: Tumor Necrosis Factor Inhibitors
20: IL-17 and IL-23 inhibitors; and targeted synthetic DMARDs
21: Living with the disease and its socioeconomic impact
22: Fused (ankylosed) spine and risk of fractures
23: Surgical treatment
24: Nontraditional (complementary or alternative) therapy
25: Disease course and effect on lifespan
26: Illustrative case histories
Appendix 1: Patient support groups and organizations
Appendix 2: Glossary
Appendix 3: List of abbreviations
Appendix 4: References and further reading
1: What is ankylosing spondylitis?
2: What is axial spondyloarthritis?
3: What is the underlying cause? HLA-B27 and other disease predisposing genes
4: Disease prevalence
5: Early symptoms
6: Eye inflammation (acute anterior uveitis)
7: Other manifestations
8: Findings on clinical examination and laboratory tests
9: Radiology, MRI, and CT
10: Diagnosis of other forms of SpA and 'look-alikes'
11: Other causes of chronic back pain
12: Assessment of disease activity and functional impairment
13: Patient education
14: Exercise and physical therapy
15: Management: An Overview
16: Management: Patient's role
17: Management: Rheumatologist's role
18: NSAIDs and conventional DMARDs
19: Tumor Necrosis Factor Inhibitors
20: IL-17 and IL-23 inhibitors; and targeted synthetic DMARDs
21: Living with the disease and its socioeconomic impact
22: Fused (ankylosed) spine and risk of fractures
23: Surgical treatment
24: Nontraditional (complementary or alternative) therapy
25: Disease course and effect on lifespan
26: Illustrative case histories
Appendix 1: Patient support groups and organizations
Appendix 2: Glossary
Appendix 3: List of abbreviations
Appendix 4: References and further reading
2: What is axial spondyloarthritis?
3: What is the underlying cause? HLA-B27 and other disease predisposing genes
4: Disease prevalence
5: Early symptoms
6: Eye inflammation (acute anterior uveitis)
7: Other manifestations
8: Findings on clinical examination and laboratory tests
9: Radiology, MRI, and CT
10: Diagnosis of other forms of SpA and 'look-alikes'
11: Other causes of chronic back pain
12: Assessment of disease activity and functional impairment
13: Patient education
14: Exercise and physical therapy
15: Management: An Overview
16: Management: Patient's role
17: Management: Rheumatologist's role
18: NSAIDs and conventional DMARDs
19: Tumor Necrosis Factor Inhibitors
20: IL-17 and IL-23 inhibitors; and targeted synthetic DMARDs
21: Living with the disease and its socioeconomic impact
22: Fused (ankylosed) spine and risk of fractures
23: Surgical treatment
24: Nontraditional (complementary or alternative) therapy
25: Disease course and effect on lifespan
26: Illustrative case histories
Appendix 1: Patient support groups and organizations
Appendix 2: Glossary
Appendix 3: List of abbreviations
Appendix 4: References and further reading